Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Failure | 29 | 2024 | 11857 | 1.810 |
Why?
|
Renal Insufficiency, Chronic | 14 | 2024 | 2291 | 1.590 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 11 | 2023 | 1518 | 1.580 |
Why?
|
Angiotensin Receptor Antagonists | 8 | 2023 | 1066 | 1.350 |
Why?
|
Acidosis | 2 | 2022 | 271 | 1.260 |
Why?
|
Hemodynamics | 7 | 2024 | 4202 | 1.010 |
Why?
|
Glomerular Filtration Rate | 6 | 2021 | 2226 | 0.980 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2024 | 152 | 0.850 |
Why?
|
Kidney | 9 | 2023 | 7064 | 0.800 |
Why?
|
Enteritis | 1 | 2021 | 164 | 0.690 |
Why?
|
Ventricular Function, Right | 3 | 2019 | 629 | 0.690 |
Why?
|
Acute Generalized Exanthematous Pustulosis | 1 | 2019 | 15 | 0.680 |
Why?
|
Mupirocin | 1 | 2019 | 55 | 0.670 |
Why?
|
Diuretics | 3 | 2021 | 612 | 0.670 |
Why?
|
Sodium Bicarbonate | 1 | 2019 | 60 | 0.670 |
Why?
|
Cardiovascular System | 3 | 2023 | 838 | 0.660 |
Why?
|
Acute Kidney Injury | 7 | 2021 | 1943 | 0.650 |
Why?
|
Ventricular Dysfunction, Left | 4 | 2023 | 2145 | 0.640 |
Why?
|
Hospital Mortality | 17 | 2021 | 5371 | 0.620 |
Why?
|
Diabetic Ketoacidosis | 1 | 2022 | 255 | 0.620 |
Why?
|
Ophthalmic Solutions | 1 | 2019 | 315 | 0.610 |
Why?
|
Stroke Volume | 11 | 2024 | 5620 | 0.610 |
Why?
|
Dexmedetomidine | 1 | 2022 | 320 | 0.600 |
Why?
|
Histiocytic Necrotizing Lymphadenitis | 1 | 2018 | 27 | 0.600 |
Why?
|
CADASIL | 1 | 2018 | 83 | 0.590 |
Why?
|
Ciprofloxacin | 1 | 2019 | 313 | 0.590 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2022 | 628 | 0.580 |
Why?
|
Heart Ventricles | 3 | 2018 | 3839 | 0.550 |
Why?
|
Hypothermia | 1 | 2018 | 188 | 0.520 |
Why?
|
Heart Block | 1 | 2018 | 390 | 0.520 |
Why?
|
Exanthema | 1 | 2021 | 504 | 0.520 |
Why?
|
Diabetic Nephropathies | 1 | 2023 | 975 | 0.510 |
Why?
|
Angioedema | 3 | 2021 | 184 | 0.500 |
Why?
|
Cocaine-Related Disorders | 1 | 2018 | 461 | 0.500 |
Why?
|
Randomized Controlled Trials as Topic | 10 | 2024 | 10358 | 0.470 |
Why?
|
Diabetes Mellitus | 4 | 2022 | 5887 | 0.470 |
Why?
|
Renal Insufficiency | 2 | 2024 | 809 | 0.450 |
Why?
|
Mitral Valve | 2 | 2020 | 1473 | 0.440 |
Why?
|
Glucocorticoids | 2 | 2019 | 2170 | 0.420 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2018 | 1244 | 0.420 |
Why?
|
Chest Pain | 1 | 2018 | 1099 | 0.380 |
Why?
|
Diabetes Mellitus, Type 2 | 7 | 2024 | 12242 | 0.380 |
Why?
|
Humans | 100 | 2024 | 768451 | 0.370 |
Why?
|
Renal Dialysis | 4 | 2024 | 1802 | 0.340 |
Why?
|
Pandemics | 8 | 2021 | 8753 | 0.320 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2021 | 2173 | 0.310 |
Why?
|
Echocardiography | 4 | 2021 | 5043 | 0.310 |
Why?
|
Retrospective Studies | 39 | 2024 | 81834 | 0.310 |
Why?
|
Coronavirus Infections | 6 | 2020 | 3116 | 0.300 |
Why?
|
Anterior Wall Myocardial Infarction | 2 | 2018 | 42 | 0.300 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2019 | 1569 | 0.300 |
Why?
|
Pneumonia, Viral | 6 | 2020 | 3240 | 0.300 |
Why?
|
Critical Illness | 2 | 2021 | 2754 | 0.290 |
Why?
|
Hypertension, Pulmonary | 3 | 2024 | 1605 | 0.290 |
Why?
|
Fluid Therapy | 2 | 2022 | 585 | 0.290 |
Why?
|
Resuscitation | 2 | 2022 | 680 | 0.270 |
Why?
|
Patient Readmission | 5 | 2021 | 3308 | 0.270 |
Why?
|
Skin | 1 | 2019 | 4520 | 0.260 |
Why?
|
Pulmonary Embolism | 3 | 2023 | 2591 | 0.250 |
Why?
|
Hospitalization | 16 | 2024 | 10845 | 0.240 |
Why?
|
Aged | 39 | 2024 | 171520 | 0.240 |
Why?
|
Midodrine | 1 | 2024 | 24 | 0.230 |
Why?
|
Multimedia | 1 | 2024 | 76 | 0.230 |
Why?
|
Pulmonary Infarction | 1 | 2023 | 11 | 0.220 |
Why?
|
Female | 47 | 2024 | 396943 | 0.220 |
Why?
|
Cardiac Surgical Procedures | 1 | 2019 | 3682 | 0.210 |
Why?
|
Mineralocorticoids | 1 | 2023 | 37 | 0.210 |
Why?
|
Diuresis | 1 | 2022 | 106 | 0.200 |
Why?
|
Male | 44 | 2024 | 364781 | 0.200 |
Why?
|
Middle Aged | 33 | 2024 | 223418 | 0.200 |
Why?
|
Receptors, Mineralocorticoid | 1 | 2023 | 167 | 0.190 |
Why?
|
Dihydropyridines | 1 | 2021 | 67 | 0.190 |
Why?
|
Hypertension | 3 | 2022 | 8611 | 0.190 |
Why?
|
Calcinosis | 2 | 2020 | 1485 | 0.190 |
Why?
|
Osmolar Concentration | 1 | 2022 | 659 | 0.190 |
Why?
|
Electrolytes | 1 | 2022 | 278 | 0.180 |
Why?
|
Lisinopril | 1 | 2021 | 60 | 0.180 |
Why?
|
Hemofiltration | 1 | 2020 | 59 | 0.180 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2021 | 110 | 0.170 |
Why?
|
Stroke | 2 | 2021 | 9791 | 0.170 |
Why?
|
Conjunctivitis, Bacterial | 1 | 2019 | 22 | 0.170 |
Why?
|
Emollients | 1 | 2019 | 42 | 0.170 |
Why?
|
Atrial Function, Right | 1 | 2019 | 32 | 0.170 |
Why?
|
Hypoglycemic Agents | 3 | 2021 | 3111 | 0.170 |
Why?
|
Ascites | 1 | 2021 | 339 | 0.170 |
Why?
|
Echocardiography, Stress | 1 | 2020 | 139 | 0.160 |
Why?
|
Carcinoid Heart Disease | 1 | 2019 | 11 | 0.160 |
Why?
|
Cardiomyopathy, Alcoholic | 1 | 2018 | 6 | 0.160 |
Why?
|
Acute Coronary Syndrome | 2 | 2023 | 2195 | 0.160 |
Why?
|
Polycythemia Vera | 1 | 2020 | 161 | 0.160 |
Why?
|
Time Factors | 12 | 2021 | 40271 | 0.160 |
Why?
|
Liver Cirrhosis | 3 | 2024 | 1950 | 0.160 |
Why?
|
Administration, Oral | 2 | 2024 | 4041 | 0.160 |
Why?
|
Relief Work | 1 | 2020 | 131 | 0.160 |
Why?
|
Treatment Outcome | 11 | 2024 | 65409 | 0.160 |
Why?
|
Thrombosis | 3 | 2023 | 2956 | 0.150 |
Why?
|
Tranexamic Acid | 1 | 2021 | 174 | 0.150 |
Why?
|
Hyperuricemia | 1 | 2021 | 223 | 0.150 |
Why?
|
Environmental Health | 1 | 2021 | 295 | 0.150 |
Why?
|
Risk Factors | 19 | 2023 | 74915 | 0.150 |
Why?
|
Hospitals, Urban | 1 | 2020 | 501 | 0.150 |
Why?
|
Venous Thromboembolism | 2 | 2021 | 1884 | 0.150 |
Why?
|
Veterans | 2 | 2022 | 2671 | 0.150 |
Why?
|
Catheters, Indwelling | 1 | 2020 | 436 | 0.150 |
Why?
|
Medically Underserved Area | 1 | 2020 | 266 | 0.150 |
Why?
|
Mitral Valve Stenosis | 1 | 2020 | 342 | 0.150 |
Why?
|
Eligibility Determination | 1 | 2021 | 420 | 0.150 |
Why?
|
Coronavirus | 1 | 2020 | 156 | 0.150 |
Why?
|
Out-of-Hospital Cardiac Arrest | 1 | 2022 | 340 | 0.150 |
Why?
|
Administration, Topical | 1 | 2019 | 707 | 0.150 |
Why?
|
Antifibrinolytic Agents | 1 | 2021 | 289 | 0.140 |
Why?
|
Hemorrhage | 2 | 2020 | 3458 | 0.140 |
Why?
|
Hyperostosis, Diffuse Idiopathic Skeletal | 1 | 2017 | 23 | 0.140 |
Why?
|
Cardiovascular Diseases | 5 | 2024 | 15638 | 0.140 |
Why?
|
Ascorbic Acid | 1 | 2020 | 658 | 0.140 |
Why?
|
Drug Substitution | 1 | 2019 | 291 | 0.140 |
Why?
|
Biopsy | 2 | 2019 | 6816 | 0.140 |
Why?
|
Peripartum Period | 1 | 2018 | 138 | 0.140 |
Why?
|
Foot | 1 | 2021 | 577 | 0.140 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2021 | 347 | 0.140 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 18048 | 0.130 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2018 | 125 | 0.130 |
Why?
|
Benzodiazepines | 1 | 2022 | 1139 | 0.130 |
Why?
|
Endocarditis | 1 | 2020 | 355 | 0.130 |
Why?
|
Echocardiography, Doppler | 1 | 2020 | 899 | 0.130 |
Why?
|
Intubation, Intratracheal | 2 | 2021 | 1359 | 0.130 |
Why?
|
Philadelphia | 3 | 2021 | 271 | 0.130 |
Why?
|
Prognosis | 7 | 2023 | 30028 | 0.130 |
Why?
|
Albuminuria | 1 | 2019 | 658 | 0.130 |
Why?
|
Comorbidity | 8 | 2021 | 10601 | 0.130 |
Why?
|
Hand | 1 | 2021 | 907 | 0.120 |
Why?
|
Withholding Treatment | 1 | 2019 | 621 | 0.120 |
Why?
|
Aged, 80 and over | 11 | 2023 | 59680 | 0.120 |
Why?
|
Cohort Studies | 6 | 2024 | 41797 | 0.120 |
Why?
|
Thromboembolism | 2 | 2018 | 1006 | 0.120 |
Why?
|
Abdominal Pain | 1 | 2021 | 1070 | 0.120 |
Why?
|
Exercise Tolerance | 1 | 2020 | 849 | 0.120 |
Why?
|
Respiratory Insufficiency | 1 | 2023 | 1244 | 0.120 |
Why?
|
Follow-Up Studies | 7 | 2023 | 39430 | 0.120 |
Why?
|
Diarrhea | 1 | 2021 | 1320 | 0.120 |
Why?
|
Patient Education as Topic | 1 | 2024 | 2339 | 0.120 |
Why?
|
Antihypertensive Agents | 2 | 2023 | 2028 | 0.110 |
Why?
|
Breast Neoplasms | 2 | 2021 | 21156 | 0.110 |
Why?
|
Anemia | 1 | 2023 | 1521 | 0.110 |
Why?
|
Acute Disease | 5 | 2023 | 7246 | 0.110 |
Why?
|
Disease Progression | 5 | 2023 | 13655 | 0.110 |
Why?
|
Thrombolytic Therapy | 2 | 2023 | 2058 | 0.110 |
Why?
|
Inpatients | 2 | 2024 | 2561 | 0.110 |
Why?
|
American Heart Association | 3 | 2023 | 1049 | 0.110 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 13026 | 0.110 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2019 | 645 | 0.110 |
Why?
|
Dyslipidemias | 1 | 2021 | 874 | 0.110 |
Why?
|
Prednisone | 1 | 2018 | 1568 | 0.110 |
Why?
|
Ventricular Function, Left | 3 | 2022 | 3941 | 0.110 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2020 | 1126 | 0.100 |
Why?
|
Myocardial Infarction | 2 | 2024 | 11515 | 0.100 |
Why?
|
Lymphocytes | 1 | 2020 | 2611 | 0.100 |
Why?
|
Intensive Care Units | 3 | 2022 | 3805 | 0.100 |
Why?
|
Bacterial Infections | 1 | 2020 | 1397 | 0.100 |
Why?
|
Exercise Test | 1 | 2020 | 2186 | 0.100 |
Why?
|
Risk Assessment | 5 | 2023 | 24311 | 0.100 |
Why?
|
Vitamins | 1 | 2020 | 1638 | 0.100 |
Why?
|
Hospital Costs | 1 | 2018 | 959 | 0.100 |
Why?
|
United States | 15 | 2024 | 73121 | 0.100 |
Why?
|
Anti-Bacterial Agents | 2 | 2020 | 7471 | 0.090 |
Why?
|
Anticoagulants | 3 | 2023 | 4840 | 0.090 |
Why?
|
Patient Admission | 1 | 2018 | 1370 | 0.090 |
Why?
|
Deglutition Disorders | 1 | 2017 | 637 | 0.090 |
Why?
|
Pulmonary Artery | 1 | 2019 | 1949 | 0.090 |
Why?
|
Heart Arrest | 1 | 2021 | 1516 | 0.090 |
Why?
|
Aortic Valve | 1 | 2020 | 1968 | 0.090 |
Why?
|
Adult | 15 | 2024 | 223542 | 0.090 |
Why?
|
Kidney Diseases | 1 | 2021 | 2102 | 0.090 |
Why?
|
Length of Stay | 2 | 2022 | 6521 | 0.090 |
Why?
|
Obesity, Morbid | 1 | 2021 | 1309 | 0.090 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2024 | 4049 | 0.080 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2022 | 2331 | 0.080 |
Why?
|
Troponin | 2 | 2023 | 534 | 0.080 |
Why?
|
Blood Platelets | 1 | 2020 | 2485 | 0.080 |
Why?
|
Insulin | 2 | 2021 | 6606 | 0.080 |
Why?
|
Patient Selection | 1 | 2021 | 4266 | 0.080 |
Why?
|
Vasoconstrictor Agents | 2 | 2024 | 658 | 0.080 |
Why?
|
Diagnostic Imaging | 2 | 2023 | 3543 | 0.080 |
Why?
|
Fibrin Fibrinogen Degradation Products | 2 | 2021 | 425 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2659 | 0.080 |
Why?
|
Urban Population | 3 | 2021 | 2047 | 0.080 |
Why?
|
Calcium Channel Blockers | 2 | 2021 | 692 | 0.080 |
Why?
|
Pregnancy Complications | 1 | 2022 | 2969 | 0.080 |
Why?
|
Disease Management | 1 | 2019 | 2533 | 0.070 |
Why?
|
Aortic Valve Stenosis | 1 | 2020 | 2032 | 0.070 |
Why?
|
Neutrophils | 1 | 2020 | 3790 | 0.070 |
Why?
|
Health Care Costs | 1 | 2020 | 3265 | 0.070 |
Why?
|
Renin-Angiotensin System | 2 | 2023 | 735 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 3 | 2021 | 1816 | 0.070 |
Why?
|
Epilepsy | 1 | 2022 | 3324 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2022 | 4362 | 0.070 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 3246 | 0.070 |
Why?
|
Aftercare | 2 | 2023 | 921 | 0.070 |
Why?
|
Hydroxychloroquine | 2 | 2020 | 427 | 0.070 |
Why?
|
Respiration, Artificial | 3 | 2023 | 2723 | 0.060 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2020 | 3440 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2021 | 3253 | 0.060 |
Why?
|
Cardiomyopathies | 1 | 2018 | 2056 | 0.060 |
Why?
|
Kidney Transplantation | 1 | 2020 | 4285 | 0.060 |
Why?
|
Sex Distribution | 2 | 2020 | 2286 | 0.060 |
Why?
|
Electrocardiography | 1 | 2018 | 6410 | 0.060 |
Why?
|
Age Distribution | 2 | 2020 | 2881 | 0.060 |
Why?
|
Prospective Studies | 3 | 2024 | 54914 | 0.050 |
Why?
|
Atherosclerosis | 1 | 2019 | 3431 | 0.050 |
Why?
|
Pulmonary Wedge Pressure | 1 | 2024 | 278 | 0.050 |
Why?
|
Atrial Fibrillation | 1 | 2021 | 5162 | 0.050 |
Why?
|
Algorithms | 1 | 2023 | 14158 | 0.050 |
Why?
|
Severity of Illness Index | 4 | 2020 | 15965 | 0.050 |
Why?
|
Asthma | 1 | 2021 | 6274 | 0.050 |
Why?
|
Logistic Models | 3 | 2021 | 13324 | 0.050 |
Why?
|
Coronary Artery Disease | 1 | 2021 | 6551 | 0.050 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2024 | 291 | 0.050 |
Why?
|
Arteriovenous Fistula | 1 | 2024 | 321 | 0.050 |
Why?
|
Melena | 1 | 2020 | 32 | 0.050 |
Why?
|
Survival Rate | 3 | 2020 | 12875 | 0.050 |
Why?
|
Hemoglobin A | 1 | 2020 | 84 | 0.040 |
Why?
|
Incidence | 4 | 2020 | 21552 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2021 | 15460 | 0.040 |
Why?
|
Ultrafiltration | 1 | 2020 | 48 | 0.040 |
Why?
|
Off-Label Use | 1 | 2021 | 186 | 0.040 |
Why?
|
Kidney Failure, Chronic | 2 | 2024 | 2489 | 0.040 |
Why?
|
Pennsylvania | 1 | 2021 | 616 | 0.040 |
Why?
|
Neprilysin | 1 | 2022 | 487 | 0.040 |
Why?
|
Blood Cell Count | 1 | 2020 | 402 | 0.040 |
Why?
|
Patient Discharge | 2 | 2023 | 3471 | 0.040 |
Why?
|
Mortality | 2 | 2021 | 2917 | 0.040 |
Why?
|
Prevalence | 3 | 2020 | 15880 | 0.040 |
Why?
|
Methylprednisolone | 1 | 2020 | 387 | 0.040 |
Why?
|
Adolescent | 3 | 2022 | 89168 | 0.040 |
Why?
|
Bicycling | 1 | 2020 | 178 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2020 | 20762 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2021 | 20231 | 0.040 |
Why?
|
Chlorides | 1 | 2021 | 663 | 0.040 |
Why?
|
Aldosterone | 1 | 2023 | 875 | 0.040 |
Why?
|
Antiviral Agents | 2 | 2020 | 3063 | 0.040 |
Why?
|
Cities | 1 | 2020 | 546 | 0.040 |
Why?
|
Young Adult | 3 | 2020 | 60045 | 0.040 |
Why?
|
Demography | 1 | 2022 | 1643 | 0.040 |
Why?
|
Hyperkalemia | 1 | 2020 | 233 | 0.040 |
Why?
|
Hemoglobins | 1 | 2023 | 1532 | 0.040 |
Why?
|
Multivariate Analysis | 2 | 2021 | 12096 | 0.040 |
Why?
|
Ferritins | 1 | 2020 | 601 | 0.040 |
Why?
|
Creatinine | 1 | 2023 | 1915 | 0.040 |
Why?
|
Blood Transfusion | 1 | 2023 | 1308 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2019 | 15880 | 0.030 |
Why?
|
Glucosides | 1 | 2021 | 532 | 0.030 |
Why?
|
Respiratory Mechanics | 1 | 2021 | 722 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2023 | 26351 | 0.030 |
Why?
|
Awareness | 1 | 2020 | 654 | 0.030 |
Why?
|
Palliative Care | 2 | 2022 | 3644 | 0.030 |
Why?
|
Sodium | 1 | 2021 | 1595 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2020 | 1840 | 0.030 |
Why?
|
Vulnerable Populations | 1 | 2021 | 717 | 0.030 |
Why?
|
Steroids | 1 | 2020 | 937 | 0.030 |
Why?
|
Uric Acid | 1 | 2021 | 807 | 0.030 |
Why?
|
Benzhydryl Compounds | 1 | 2021 | 939 | 0.030 |
Why?
|
HIV Infections | 1 | 2020 | 17564 | 0.030 |
Why?
|
Bacteremia | 1 | 2020 | 985 | 0.030 |
Why?
|
Antimalarials | 1 | 2020 | 910 | 0.030 |
Why?
|
Morbidity | 1 | 2019 | 1760 | 0.030 |
Why?
|
Databases, Factual | 2 | 2018 | 8081 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2020 | 22293 | 0.030 |
Why?
|
Staphylococcus aureus | 1 | 2020 | 1461 | 0.030 |
Why?
|
Dyspnea | 1 | 2020 | 1352 | 0.020 |
Why?
|
Anticonvulsants | 1 | 2022 | 1923 | 0.020 |
Why?
|
Coronary Angiography | 1 | 2023 | 4526 | 0.020 |
Why?
|
Propensity Score | 1 | 2018 | 1971 | 0.020 |
Why?
|
Cervical Vertebrae | 1 | 2017 | 982 | 0.020 |
Why?
|
Neoplasms | 1 | 2019 | 22386 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6320 | 0.020 |
Why?
|
Heart | 1 | 2023 | 4451 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2020 | 2666 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5308 | 0.020 |
Why?
|
Contrast Media | 1 | 2022 | 5336 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2022 | 3629 | 0.020 |
Why?
|
Fibrinolytic Agents | 1 | 2018 | 2082 | 0.020 |
Why?
|
Odds Ratio | 1 | 2020 | 9687 | 0.020 |
Why?
|
Calcium | 1 | 2021 | 5793 | 0.020 |
Why?
|
Risk | 1 | 2020 | 9642 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2022 | 3230 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10125 | 0.020 |
Why?
|
Blood Pressure | 1 | 2022 | 8538 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8559 | 0.020 |
Why?
|
Blood Glucose | 1 | 2020 | 6429 | 0.020 |
Why?
|
Heart Diseases | 1 | 2018 | 2816 | 0.020 |
Why?
|
Age Factors | 1 | 2021 | 18478 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8051 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2019 | 4877 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 2018 | 4453 | 0.010 |
Why?
|
Smoking | 1 | 2018 | 9099 | 0.010 |
Why?
|
Inflammation | 1 | 2020 | 10865 | 0.010 |
Why?
|
Pregnancy | 1 | 2022 | 30179 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2019 | 6978 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2019 | 11206 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2019 | 13589 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2022 | 36840 | 0.010 |
Why?
|